Roche Holding AG (RHHVF)
242.20
+2.14
(+0.89%)
USD |
OTCM |
Apr 19, 14:47
Roche 1 Year Total Returns (Daily): -18.57% for April 18, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| April 18, 2024 | -18.57% |
| April 17, 2024 | -18.23% |
| April 16, 2024 | -17.40% |
| April 15, 2024 | -17.07% |
| April 12, 2024 | -16.85% |
| April 11, 2024 | -15.00% |
| April 10, 2024 | -15.56% |
| April 09, 2024 | -16.76% |
| April 08, 2024 | -17.55% |
| April 05, 2024 | -14.60% |
| April 04, 2024 | -10.97% |
| April 03, 2024 | -8.31% |
| April 02, 2024 | -7.99% |
| April 01, 2024 | -7.10% |
| March 28, 2024 | -3.35% |
| March 27, 2024 | -5.64% |
| March 26, 2024 | -8.59% |
| March 25, 2024 | -7.58% |
| March 22, 2024 | -7.96% |
| March 21, 2024 | -7.69% |
| March 20, 2024 | -3.70% |
| March 19, 2024 | -3.55% |
| March 18, 2024 | -4.08% |
| March 15, 2024 | -0.86% |
| March 14, 2024 | -1.29% |
| Date | Value |
|---|---|
| March 13, 2024 | -2.90% |
| March 12, 2024 | 2.42% |
| March 11, 2024 | 0.00% |
| March 08, 2024 | -0.35% |
| March 07, 2024 | -2.02% |
| March 06, 2024 | -3.99% |
| March 05, 2024 | -6.15% |
| March 04, 2024 | -7.73% |
| March 01, 2024 | -6.05% |
| February 29, 2024 | -7.75% |
| February 28, 2024 | -6.80% |
| February 27, 2024 | -5.85% |
| February 26, 2024 | -9.23% |
| February 23, 2024 | -7.44% |
| February 22, 2024 | -12.58% |
| February 21, 2024 | -10.37% |
| February 20, 2024 | -10.69% |
| February 16, 2024 | -11.29% |
| February 15, 2024 | -10.50% |
| February 14, 2024 | -13.80% |
| February 13, 2024 | -13.08% |
| February 12, 2024 | -12.42% |
| February 09, 2024 | -12.61% |
| February 08, 2024 | -13.52% |
| February 07, 2024 | -12.12% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-28.70%
Minimum
Mar 27 2023
42.00%
Maximum
Dec 27 2019
7.06%
Average
8.47%
Median
1 Year Total Returns (Daily) Benchmarks
| AC Immune SA | 7.94% |
| CRISPR Therapeutics AG | 8.13% |
| Addex Therapeutics Ltd | 59.41% |
| NLS Pharmaceutics Ltd | -91.12% |